TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy

Dougall, WC; Kurtulus, S; Smyth, MJ; Anderson, AC

Anderson, AC (reprint author), Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, 75 Francis St, Boston, MA 02115 USA.; Anderson, AC (reprint author), Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.; Anderson, AC (re

IMMUNOLOGICAL REVIEWS, 2017; 276 (1): 112

Abstract

While therapies targeting the co-inhibitory or immune checkpoint receptors PD-1 and CTLA-4 have shown remarkable success in many cancers, not all pati......

Full Text Link